250 related articles for article (PubMed ID: 27973560)
1. Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD.
Fairoozy RH; White J; Palmen J; Kalea AZ; Humphries SE
PLoS One; 2016; 11(12):e0167676. PubMed ID: 27973560
[TBL] [Abstract][Full Text] [Related]
2. Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
Fairoozy RH; Cooper J; White J; Giambartolomei C; Folkersen L; Wannamethee SG; Jefferis BJ; Whincup P; Ben-Shlomo Y; Kumari M; Kivimaki M; Wong A; Hardy R; Kuh D; Gaunt TR; Casas JP; McLachlan S; Price JF; Hingorani A; Franco-Cereceda A; Grewal T; Kalea AZ; Humphries SE;
Atherosclerosis; 2017 Jun; 261():60-68. PubMed ID: 28456096
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia.
De Castro-Orós I; Pérez-López J; Mateo-Gallego R; Rebollar S; Ledesma M; León M; Cofán M; Casasnovas JA; Ros E; Rodríguez-Rey JC; Civeira F; Pocoví M
BMC Med Genomics; 2014 Apr; 7():17. PubMed ID: 24708769
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of low density lipoprotein receptor (LDLR) rs2228671 polymorphism and coronary heart disease.
Ye H; Zhao Q; Huang Y; Wang L; Liu H; Wang C; Dai D; Xu L; Ye M; Duan S
Biomed Res Int; 2014; 2014():564940. PubMed ID: 24900971
[TBL] [Abstract][Full Text] [Related]
5. Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response.
Chen W; Wang S; Ma Y; Zhou Y; Liu H; Strnad P; Kraemer FB; Krauss RM; Liu J
Int J Mol Med; 2008 Mar; 21(3):345-53. PubMed ID: 18288382
[TBL] [Abstract][Full Text] [Related]
6. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study.
Linsel-Nitschke P; Götz A; Erdmann J; Braenne I; Braund P; Hengstenberg C; Stark K; Fischer M; Schreiber S; El Mokhtari NE; Schaefer A; Schrezenmeir J; Rubin D; Hinney A; Reinehr T; Roth C; Ortlepp J; Hanrath P; Hall AS; Mangino M; Lieb W; Lamina C; Heid IM; Doering A; Gieger C; Peters A; Meitinger T; Wichmann HE; König IR; Ziegler A; Kronenberg F; Samani NJ; Schunkert H; ;
PLoS One; 2008 Aug; 3(8):e2986. PubMed ID: 18714375
[TBL] [Abstract][Full Text] [Related]
7. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
8. Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels.
Cavalli M; Pan G; Nord H; Wadelius C
Lipids Health Dis; 2016 Jan; 15():18. PubMed ID: 26817450
[TBL] [Abstract][Full Text] [Related]
9. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.
Obirikorang C; Acheampong E; Quaye L; Yorke J; Amos-Abanyie EK; Akyaw PA; Anto EO; Bani SB; Asamoah EA; Batu EN
PLoS One; 2020; 15(1):e0227779. PubMed ID: 31929604
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER.
Polisecki E; Muallem H; Maeda N; Peter I; Robertson M; McMahon AD; Ford I; Packard C; Shepherd J; Jukema JW; Westendorp RG; de Craen AJ; Buckley BM; Ordovas JM; Schaefer EJ;
Atherosclerosis; 2008 Sep; 200(1):109-14. PubMed ID: 18261733
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase gene polymorphism rs1059611 functionally influences serum lipid concentrations.
Mo X; Liu X; Wang L; Li H; Lu X; Huang J; Chen J; Cao J; Li J; Chen S; Tang Y; Peng X; Gu D
Atherosclerosis; 2013 Aug; 229(2):511-6. PubMed ID: 23735640
[TBL] [Abstract][Full Text] [Related]
12. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.
Chen Q; Reis SE; Kammerer C; Craig WY; LaPierre SE; Zimmer EL; McNamara DM; Pauly DF; Sharaf B; Holubkov R; Bairey Merz CN; Sopko G; Bontempo F; Kamboh MI
Circulation; 2003 Jul; 107(25):3146-51. PubMed ID: 12810610
[TBL] [Abstract][Full Text] [Related]
14. Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations.
Hayat M; Kerr R; Bentley AR; Rotimi CN; Raal FJ; Ramsay M
PLoS One; 2020; 15(2):e0229098. PubMed ID: 32084179
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.
Chen Q; Razzaghi H; Demirci FY; Kamboh MI
Atherosclerosis; 2008 Sep; 200(1):102-8. PubMed ID: 18242618
[TBL] [Abstract][Full Text] [Related]
16. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Do R; Stitziel NO; Won HH; Jørgensen AB; Duga S; Angelica Merlini P; Kiezun A; Farrall M; Goel A; Zuk O; Guella I; Asselta R; Lange LA; Peloso GM; Auer PL; ; Girelli D; Martinelli N; Farlow DN; DePristo MA; Roberts R; Stewart AF; Saleheen D; Danesh J; Epstein SE; Sivapalaratnam S; Hovingh GK; Kastelein JJ; Samani NJ; Schunkert H; Erdmann J; Shah SH; Kraus WE; Davies R; Nikpay M; Johansen CT; Wang J; Hegele RA; Hechter E; Marz W; Kleber ME; Huang J; Johnson AD; Li M; Burke GL; Gross M; Liu Y; Assimes TL; Heiss G; Lange EM; Folsom AR; Taylor HA; Olivieri O; Hamsten A; Clarke R; Reilly DF; Yin W; Rivas MA; Donnelly P; Rossouw JE; Psaty BM; Herrington DM; Wilson JG; Rich SS; Bamshad MJ; Tracy RP; Cupples LA; Rader DJ; Reilly MP; Spertus JA; Cresci S; Hartiala J; Tang WH; Hazen SL; Allayee H; Reiner AP; Carlson CS; Kooperberg C; Jackson RD; Boerwinkle E; Lander ES; Schwartz SM; Siscovick DS; McPherson R; Tybjaerg-Hansen A; Abecasis GR; Watkins H; Nickerson DA; Ardissino D; Sunyaev SR; O'Donnell CJ; Altshuler D; Gabriel S; Kathiresan S
Nature; 2015 Feb; 518(7537):102-6. PubMed ID: 25487149
[TBL] [Abstract][Full Text] [Related]
17. Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease.
Tada H; Won HH; Melander O; Yang J; Peloso GM; Kathiresan S
Circ Cardiovasc Genet; 2014 Oct; 7(5):583-7. PubMed ID: 25170055
[TBL] [Abstract][Full Text] [Related]
18. A Common Polymorphism in the
Beehler K; Nikpay M; Lau P; Dang AT; Lagace TA; Soubeyrand S; McPherson R
Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):2252-2262. PubMed ID: 34134519
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
[TBL] [Abstract][Full Text] [Related]
20. Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.
Smith AJ; Palmen J; Putt W; Talmud PJ; Humphries SE; Drenos F
Hum Mol Genet; 2010 Oct; 19(20):3936-47. PubMed ID: 20650961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
